ストックスクリーナーアプリを入手
0.3365
6.10%
-0.0288
前日終値:
$0.3653
開ける：
$0.356
24時間の取引高:
695.83K
Relative Volume:
0.05
時価総額：
$14.33M
収益：
$20.27M
当期純損益:
$-63.80M
株価収益率:
-0.2214
EPS:
-1.52
ネットキャッシュフロー:
$-68.35M
1週間 パフォーマンス:
-11.05%
1か月 パフォーマンス:
-14.38%
6か月 パフォーマンス:
-32.04%
1年 パフォーマンス:
-69.38%
1日の値動き範囲:
$0.32
$0.364
1週間の範囲:
$0.32
$0.4067
52週間の値動き範囲:
$0.1417
$1.27
Carisma Therapeutics Inc Stock (CARM) Company Profile
名前
Carisma Therapeutics Inc
セクター
電話
(267) 491-6422
住所
3675 MARKET STREET, PHILADELPHIA
CARM を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
CARM
Carisma Therapeutics Inc
|
0.343 | 16.21M | 20.27M | -63.80M | -68.35M | -1.52 |
|
VRTX
Vertex Pharmaceuticals Inc
|
467.87 | 120.60B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
557.29 | 60.80B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
328.99 | 42.87B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
599.55 | 36.23B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
307.49 | 31.54B | 3.81B | -644.79M | -669.77M | -6.24 |
Carisma Therapeutics Inc Stock (CARM) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-12-12 | ダウングレード | Robert W. Baird | Outperform → Neutral |
| 2024-12-10 | ダウングレード | BTIG Research | Buy → Neutral |
| 2024-04-11 | 開始されました | BTIG Research | Buy |
| 2023-10-03 | 開始されました | CapitalOne | Overweight |
| 2023-07-06 | 開始されました | Evercore ISI | Outperform |
| 2023-05-31 | アップグレード | Jefferies | Hold → Buy |
| 2023-05-24 | 開始されました | H.C. Wainwright | Buy |
| 2023-04-14 | 開始されました | Robert W. Baird | Outperform |
すべてを表示
Carisma Therapeutics Inc (CARM) 最新ニュース
Why Carisma Therapeutics Inc. stock attracts strong analyst attentionInvestment Strategy Designed for Capital Protection - metal.it
Published on: 2025-07-28 21:04:54 - metal.it
Applying big data sentiment scoring on Carisma Therapeutics Inc.AI Volatility Forecast and Risk Monitor - Newser
Carisma Therapeutics Inc. stock outlook for YEAR Short-Term Profit Alert With Entry Forecast - Newser
Does Carisma Therapeutics Inc. stock perform well during market downturnsAchieve breakthrough gains with expert advice - jammulinksnews.com
Why is Carisma Therapeutics Inc. stock attracting strong analyst attentionRapidly growing investment returns - jammulinksnews.com
Carisma Therapeutics Inc. (NASDAQ:CARM) Receives $1.93 Average Target Price from Brokerages - Defense World
What makes Carisma Therapeutics Inc. stock price move sharplyGet alerts on the hottest market movers - jammulinksnews.com
How volatile is Carisma Therapeutics Inc. stock compared to the marketInvest confidently with professional market insights - jammulinksnews.com
How many analysts rate Carisma Therapeutics Inc. as a “Buy”Capitalize on emerging growth stocks - jammulinksnews.com
Top Risks to Consider Before Buying Carisma Therapeutics Inc. StockHigh Return Investment Tips - Newser
Has Carisma Therapeutics Inc. Stock Ever Crashed Historical Volatility ReviewFree Popular Stock Recommendations - Newser
Key External Factors That Drive Carisma Therapeutics Inc. Stock Price MovementsQuick Profit Idea Stream - Newser
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CARM, ENZB, HSON, TTNP on Behalf of Shareholders - GlobeNewswire Inc.
How high can Carisma Therapeutics Inc. stock price go in 2025Triple-digit returns - jammulinksnews.com
Published on: 2025-07-25 09:50:28 - PrintWeekIndia
Is Carisma Therapeutics Inc. a good long term investmentFree Real-Time Stock Data - Autocar Professional
Carisma Therapeutics Inc. Stock Analysis and ForecastFree Popular Stock Recommendations - PrintWeekIndia
What analysts say about Carisma Therapeutics Inc. stockExtraordinary market timing - jammulinksnews.com
What drives Carisma Therapeutics Inc. stock priceFree Stock Market Real-Time Monitoring - jammulinksnews.com
Published on: 2025-07-22 17:12:50 - jammulinksnews.com
Carisma Therapeutics Transfers Listing to Nasdaq Capital Market - TipRanks
How Carisma Therapeutics Inc. stock performs during market volatility200 Percent Profit Outlook - Newser
Carisma Therapeutics Inc (CARM) 財務データ
収益
当期純利益
現金流量
EPS
10.73%
1.99%
大文字化:
|
ボリューム (24 時間):